In this study, zinc oxide nanoparticles (ZnO NPs) were synthesized using an aqueous extract of the Ocimum lamifolium (O. lamifolium) plant. The I-optimal coordinate exchange randomized response surface methodology (RSM) was used to optimize the effect of the zinc acetate precursor, temperature, and time on ZnO NPs by designing nine runs. From ANOVA analysis, the significance and validity of the designed model showed that the optimal values of the zinc acetate precursor, temperature, and time during ZnO NPs synthesis were found to be ∼0.06 M, ∼30 °C, and ∼1.35 h, respectively. The obtained ZnO NPs under these optimized conditions were characterized and explored by UV–vis, TGA/DTA, FTIR, XRD, SEM-EDX, TEM, HRTEM, and SAED. Furthermore, the electrocatalytic performance of ZnO NPs was performed for sulfamethoxazole (SMZ) sensing activity with a 0.3528 μM (S/N = 3) limit of detection (LOD). In addition, an antibacterial study revealed that ZnO NPs confirmed an excellent zone of inhibition against E. coli, S. aureus, P. aeruginosa, and S. pyogen pathogenic drug resistance bacterial strains at concentrations of 50, 75, and 100 μg/mL. Thus, ZnO NPs synthesized using the O. lamifolium leaf have a potential electrocatalytic activity for diverse organic pollutant detection as well as a desirable material for such drug resistance antimicrobial strains.

Objective To test an intervention to increase screening for hepatitis B (HBV) in at-risk immigrants in the primary care setting. Patients and Methods From a Mayo Clinic primary care panel, we identified approximately 19,000 immigrant patients from 9 high-risk countries/ethnic groups with intermediate or high prevalences of chronic HBV. Eligible patients with no record of prior HBV testing scheduled for primary care visits within the study period spanning October 1, 2017, through October 31, 2018, were identified. During the intervention period, the primary health care professional was notified by email 1 week prior to each primary care visit and encouraged to discuss screening for HBV infection and order screening tests at the appointment. We assessed rates of HBV screening during control and intervention periods. Results We identified 597 patients in the control period and 212 patients in the intervention period who had not been screened previously for HBV. During the intervention period, 31.4% (58) of the 185 eligible patients were screened for HBV vs 7.2% (43) of the 597 eligible patients in the control period. Thus, the intervention resulted in a 4.3-fold increase in screening ( P <.00001). Of the 101 patients screened in the at-risk population, 22 (21.8%) screened positive for prior exposure to HBV (hepatitis B core antibody–positive) and 6 (5.9%) for chronic HBV infection (hepatitis B surface antigen–positive). Conclusion Notifying primary care physicians of the high-risk status of immigrant patients substantially increased screening for HBV. Identifying patients with HBV is important for monitoring disease prevalence, preventing transmission, and initiating treatment and cancer surveillance, allowing earlier recognition and prevention of chronic hepatitis, disease reactivation, cirrhosis, and hepatocellular carcinoma.

No abstract